# Long-term Registry of Patients Treated With Loncastuximab Tesirine

> **NCT05160064** · — · WITHDRAWN · sponsor: **ADC Therapeutics S.A.**

## Conditions studied

- B-Cell Lymphomas

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05160064
- **Lead sponsor:** ADC Therapeutics S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-06-30
- **Primary completion:** 2024-12
- **Final completion:** 2025-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor administrative decision
- **Last updated:** 2022-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05160064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05160064, "Long-term Registry of Patients Treated With Loncastuximab Tesirine". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05160064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*